The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation
Abstract
We hypothesized that chemoprophylaxis with the echinocandin micafungin would be an effective agent for antifungal prophylaxis during neutropenia in patients undergoing hematopoietic stem cell transplantation (HSCT). We therefore conducted a randomized, double-blind, multi-institutional, comparative phase III trial, involving 882 adult and pediatric patients, of 50 mg of micafungin (1 mg/kg for patients weighing <50 kg) and 400 mg of fluconazole (8 mg/kg for patients weighing <50 kg) administered once per day. Success was defined as the absence of suspected, proven, or probable invasive fungal infection (IFI) through the end of therapy and as the absence of proven or probable IFI through the end of the 4-week period after treatment. The overall efficacy of micafungin was superior to that of fluconazole as antifungal prophylaxis during the neutropenic phase after HSCT (80.0% in the micafungin arm vs. 73.5% in the fluconazole arm [difference, 6.5%]; 95% confidence interval, 0.9%-12%; P=.03). This randomized trial demonstrates the efficacy of an echinocandin for antifungal prophylaxis in neutropenic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Self-citationGoodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
“Proving the null hypothesis” in clinical trials
Blackwelder, W. C. (1982) · Controlled Clinical Trials · doi:10.1016/0197-2456(82)90024-1 · Cited by 887
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Winston, D. J., Chandrasekar, P. H., Lazarus, H. M., Goodman, J. L., Silber, J. L., Horowitz, H., Shadduck, R. K., Rosenfeld, C. S., Ho, W. G., Islam, M. Z., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00003 · Cited by 373
Rotstein, C., Bow, E. J., Laverdiere, M., Ioannou, S., Carr, D., Moghaddam, N., & The Canadian Fluconazole Prophylaxis Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515128 · Cited by 265
Benz, F., Knüsel, F., Nüesch, J., Treichler, H., Voser, W., Nyfeler, R., & Keller‐Schierlein, W. (1974) · Helvetica Chimica Acta · doi:10.1002/hlca.19740570818 · Cited by 253
Bartko, J. J. (1991) · American Psychologist · doi:10.1037//0003-066x.46.10.1089.a · Cited by 249
van Burik, J.-A. H., Leisenring, W., Myerson, D., Hackman, R. C., Shulman, H. M., Sale, G. E., Bowden, R. A., & McDonald, G. B. (1998) · Medicine · doi:10.1097/00005792-199807000-00003 · Cited by 205
Self-citationHovi, L., Saarinen-Pihkala, U., Vettenranta, K., & Saxen, H. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702654 · Cited by 183
Petraitis, V., Petraitiene, R., Groll, A. H., Roussillon, K., Hemmings, M., Lyman, C. A., Sein, T., Bacher, J., Bekersky, I., & Walsh, T. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1857-1869.2002 · Cited by 182
Self-citationUpdate on antifungals targeted to the cell wall: focus on β-1,3-glucan synthase inhibitors
Georgopapadakou, N. H. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.269 · Cited by 149
Groll, A. H., Mickiene, D., Petraitis, V., Petraitienė, R., Ibrahim, K. H., Piscitelli, S. C., Bekersky, I., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3322-3327.2001 · Cited by 128
Self-citationEchinocandin inhibition of 1,3‐β‐D‐glucan synthase from Candida albicans
Sawistowska-Schröder, E. T., Kerridge, D., & Perry, H. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)81032-7 · Cited by 124
Chiou, C. C., Mavrogiorgos, N., Tillem, E., Hector, R., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3310-3321.2001 · Cited by 117
Self-citationEchinocandins — An Advance in the Primary Treatment of Invasive Candidiasis
Walsh, T. J. (2002) · New England Journal of Medicine · doi:10.1056/nejme020142 · Cited by 100
Self-citationIn vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide
Mikamo, H., Sato, Y., & Tamaya, T. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.485 · Cited by 100
Antifungal Mechanism of FK463 against Candida albicans and Aspergillus fumigatus.
HATANO, K., MORISHITA, Y., Nakai, T., & Ikeda, F. (2002) · The Journal of Antibiotics · doi:10.7164/antibiotics.55.219 · Cited by 77
Nakai, T., Uno, J., Otomo, K., Ikeda, F., Tawara, S., Goto, T., Nishimura, K., & Miyaji, M. (2002) · Chemotherapy · doi:10.1159/000057666 · Cited by 67
Clinical efficacy of echinocandin antifungals
Arathoon, E. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200112000-00004 · Cited by 51
Benz, F., KNUESEL, F., Nueesch, J., TREICHLER, H., Voser, W., Nyfeler, R., & KELLER‐SCHIERLEIN, W. (1975) · ChemInform · doi:10.1002/chin.197510456 · Cited by 25
Hitting a new target with echinocandins. Why chase something else?
Graybill, J. R. (2001) · PubMed · Cited by 11
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Self-citationPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citationUllmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Metadata
- Authors
- van Burik, J.-A. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J. W., Satoi, Y., Lee, J. M., Walsh, T. J., & for the National Institute of Allergy and Infectious Diseases Mycoses Study Group
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-15
- Volume
- 39
- Issue
- 10
- Pages
- 1407-1416
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2167412063
- Cited by
- 744
- References
- 23
- FWCI
- 25.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.